Neurological Aspects of Substance Use Disorder: An Introduction
- 16 July 2024
- journal article
- editorial
- Published by Georg Thieme Verlag KG in Seminars in Neurology
- Vol. 44 (04) , 414-418
Abstract
As human beings, our greatness lies not so much in being able to remake the world… as in being able to remake ourselves. – Mahatma Gandhi Article published online: 16 July 2024 © 2024. Thieme. All rights reserved. Thieme Medical Publishers, Inc. 333 Seventh Avenue, 18th Floor, New York, NY 10001, USAKeywords
This publication has 8 references indexed in Scilit:
- Availability and Opportunities for Expansion of Buprenorphine for the Treatment of Opioid Use DisorderSeminars in Neurology, 2024
- Drug Overdose Deaths with Evidence of Counterfeit Pill Use — United States, July 2019–December 2021MMWR. Morbidity and Mortality Weekly Report, 2023
- Racial and Ethnic Disparities in Buprenorphine and Extended-Release Naltrexone Filled Prescriptions During the COVID-19 PandemicJAMA Network Open, 2022
- The role of glucagon‐like peptide 1 (GLP‐1) in addictive disordersBritish Journal of Pharmacology, 2021
- Genetics of substance use disorders: a reviewPsychological Medicine, 2021
- The legalization of cannabinoid products and standardizing cannabis-drug development in the United States: a brief reportDialogues in clinical neuroscience, 2020
- Transcranial magnetic stimulation, deep brain stimulation, and other forms of neuromodulation for substance use disorders: Review of modalities and implications for treatmentJournal of the Neurological Sciences, 2020
- Cannabis and the developing brain: What does the evidence say?Birth Defects Research, 2019